Hetrombopag Not Yet Recruiting Phase 2 Trials for Myelodysplastic Syndrome Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT05392647Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective´╝îOpen-label, Single-arm Study.